147 related articles for article (PubMed ID: 34693052)
1. Facile synthesis and
Fathy U; Abd El Salam HA; Fayed EA; Elgamal AM; Gouda A
Heliyon; 2021 Oct; 7(10):e08117. PubMed ID: 34693052
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Anticancer Activity of Novel Chromene Derivatives, Chromeno[2,3-d][1,3]Oxazines, and Chromeno[2,3-d]Pyrimidines.
Yousif MNM; Fathy U; Yousif NM
Med Chem; 2023; 19(6):578-585. PubMed ID: 36573048
[TBL] [Abstract][Full Text] [Related]
4. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and fungicidal activity of pyrazole derivatives containing 1,2,3,4-tetrahydroquinoline.
Lei P; Zhang X; Xu Y; Xu G; Liu X; Yang X; Zhang X; Ling Y
Chem Cent J; 2016; 10():40. PubMed ID: 27382411
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
8. Facile One-Pot Multicomponent Synthesis of Pyrazolo-Thiazole Substituted Pyridines with Potential Anti-Proliferative Activity: Synthesis, In Vitro and In Silico Studies.
El Azab IH; Bakr RB; Elkanzi NAA
Molecules; 2021 May; 26(11):. PubMed ID: 34067399
[TBL] [Abstract][Full Text] [Related]
9. The Recent Development of Tetrahydro-Quinoline/Isoquinoline Based Compounds as Anticancer Agents.
Yadav P; Kumar A; Althagafi I; Nemaysh V; Rai R; Pratap R
Curr Top Med Chem; 2021 Oct; 21(17):1587-1622. PubMed ID: 34042035
[TBL] [Abstract][Full Text] [Related]
10. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
[TBL] [Abstract][Full Text] [Related]
11. Iodine mediated pyrazolo-quinoline derivatives as potent anti-proliferative agents.
Kasaboina S; Ramineni V; Banu S; Bandi Y; Nagarapu L; Dumala N; Grover P
Bioorg Med Chem Lett; 2018 Feb; 28(4):664-667. PubMed ID: 29409753
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM
Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494
[TBL] [Abstract][Full Text] [Related]
13. Decision making for promising quinoline-based anticancer agents through combined methodology.
Özcan E; Ökten S; Eren T
J Biochem Mol Toxicol; 2020 Sep; 34(9):e22522. PubMed ID: 32407595
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties.
Zebbiche Z; Tekin S; Küçükbay H; Yüksel F; Boumoud B
Arch Pharm (Weinheim); 2021 May; 354(5):e2000377. PubMed ID: 33368627
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Cytotoxicity and Topoisomerase I/IIα Inhibition Activity of Pyrazolo[4,3-
Chaudhary CL; Ko S; Lee C; Kim Y; Jung C; Hyun S; Kwon Y; Kang JS; Jung JK; Lee H
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455396
[TBL] [Abstract][Full Text] [Related]
16. Annulated pyrazole derivatives as a novel class of urokinase (uPA) inhibitors: Green synthesis, anticancer activity, DNA-damage evaluation, and molecular modelling study.
Farag PS; AboulMagd AM; Hemdan MM; Hassaballah AI
Bioorg Chem; 2023 Jan; 130():106231. PubMed ID: 36335649
[TBL] [Abstract][Full Text] [Related]
17. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]